Health news High BMI isn’t enough to diagnose obesity, global expert panel says The longtime reliance on BMI means that obesity is likely overdiagnosed, members of the Commission said. 15/01/2025
Health news Weight-loss drugs like Ozempic may reduce opioid overdose rates A new study found a link between new popular GIP/GLP-1 receptor agonists and a reduced rate of overdose or intoxication in people with opioid and alcohol use disorders. 17/10/2024
Business UK to offer weight-loss jabs to unemployed with weight issues Prescribing weight-loss jabs to obese unemployed in the UK could unleash economic potential of the fat man of Europe, the health minister believes. 15/10/2024
Health news Women on weight loss drug lose more weight than men, study finds A new study found that women using the weight loss drug tirzepatide (Mounjaro) lost more weight than men, but experienced higher rates of side effects like nausea and vomiting. 13/09/2024
Lifestyle Hundreds of Italian residents join their mayor on weight loss walks A small Italian town mayor's fight to loss weight has gone viral after he campaigned for company on his weekly walks. 27/07/2024
Health news Global health authorities issue warning about fake Ozempic A new global warning was issued over falsified versions of a popular weight-loss and type 2 diabetes drug. 21/06/2024
Health news 'Ozempic breasts': What are the side effects of weight loss drugs? While many people suffering from obesity have been using Ozempic to help with weight loss, health professionals are warning of potential side effects. 19/05/2024
Health news Ozempic found to cut heart disease and keep weight off for four years New analyses of a large trial presented at the European Congress on Obesity showed the clear benefits of the popular weight-loss drug. 14/05/2024
Business How much higher can Novo Nordisk shares go? Novo Nordisk's remarkable ascent, driven by its revolutionary weight-loss drug Wegovy, has led to a surge in market value and positive analyst outlook. 14/03/2024
Health news More than one billion people globally are obese, study finds Obesity rates have increased dramatically among children, teenagers, and adults, with more than one billion people in the world now affected. 01/03/2024
Health news Ozempic, Wegovy not linked to increased risk of suicidal thoughts The researchers called for closer evaluation of reports of suicidal thoughts linked to the diabetes and obesity drugs and for patients to be followed for a longer period of time. 08/01/2024
Nutrition Europe's obesity crisis: Which countries are the most impacted? The data shows one in six Europeans with obese and over 50% of adults overweight. The rates vary from country to country but where is the problem the worst? 20/12/2023
Health news Americans turn to alternatives amid Ozempic shortage Approved in 2017 for adults with type 2 diabetes, Ozempic has now become a blockbuster weight loss drug. 04/12/2023
Business Sales skyrocket for weight-loss drug firm Novo Nordisk The Danish drugmaker expects double-digit growth to continue into 2024 as demand soars for obesity and diabetes medication. 02/11/2023
Health news UK's NHS gets limited supply of new Wegovy weight loss drug Wegovy, manufactured by Danish pharmaceutical company Novo Nordisk, is a popular new weight loss drug. 04/09/2023
Health news Weight-loss drug Wegovy could reduce risk of heart attack or stroke Danish pharmaceutical company Novo Nordisk says the medicine could reduce the risk of cardiovascular disease. But they’re also facing a lawsuit about severe side effects of its main ingredient. 09/08/2023
Health news UK launches €46.5m project to tackle obesity with weight loss drugs The UK is pouring millions into a programme to tackle obesity with weight loss drugs such as Wegovy. 07/06/2023
Health news WHO warns against long-term health risks of artificial sweeteners Artificial sweeteners won’t help with weight loss and may raise the risk of diabetes, heart disease and death, says the World Health Organization (WHO). 22/05/2023
Health news This new weight loss drug is set to rival Ozempic and Wegovy Ozempic has a new rival: Mounjaro, also a diabetes drug, has led to average weight losses of 15 to 24 kg. 28/04/2023
Food and Drink Britain's food tsar Henry Dimbleby steps down over obesity crisis Henry Dimbleby, the UK's food tsar, has quit over what he calls a 'lack of government action' over obesity in one of the worst affected countries in Europe. 20/03/2023